Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CLVS | AMGN | GILD | CELG | VRTX |
Company | Clovis Oncology Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 0.0808 | 264.63 | 66.25 | 108.01 | 394.72 |
High | 0.0977 | 267.87 | 66.72 | 108.59 | 396.98 |
Low | 0.0766 | 260.68 | 66.16 | 107.27 | 391.25 |
Last | 0.0812 | 268.14 | 66.45 | 108.24 | 392.51 |
Change | -0.0048 | +5.39 | +0.29 | +0.11 | -0.97 |
% Change | -5.58% | +2.05% | +0.44% | +0.10% | -0.25% |
Volume | 24,516,400 | 1,530,491 | 4,381,297 | 191,230,496 | 713,394 |
20-Day Average Volume | 9,433,500 | 2,149,545 | 6,137,995 | 16,188,930 | 897,186 |
Previous Close | 0.0860 | 262.75 | 66.16 | 108.13 | 393.48 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | No | Yes |
Technicals | |||||
20-Day Moving Average | 0.2340 | 272.49 | 69.89 | 108.17 | 405.43 |
20-Day Raw Stochastic | 1.73% | 24.39% | 7.63% | 63.25% | 4.89% |
20-Day Relative Strength | 23.83% | 42.39% | 29.92% | 64.69% | 36.29% |
Weighted Alpha | -91.19 | +6.87 | -24.72 | +46.30 | +15.22 |
Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Sell |
Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
Last Month's Opinion | 100% Sell | 8% Sell | 72% Sell | 100% Buy | 40% Buy |
Performance | |||||
5-Days | |||||
%Chg | -39.04% since 12/13/22 | +0.07% since 04/12/24 | -2.29% since 04/12/24 | -1.97% since 11/13/19 | -1.02% since 04/12/24 |
Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
High | 0.1439 on 12/14/22 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 402.49 on 04/15/24 |
1-Month | |||||
%Chg | -76.74% since 11/18/22 | -1.56% since 03/19/24 | -9.40% since 03/19/24 | +5.14% since 10/18/19 | -5.47% since 03/19/24 |
Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
High | 0.3772 on 12/01/22 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
3-Month | |||||
%Chg | -92.75% since 09/20/22 | -13.10% since 01/19/24 | -23.81% since 01/19/24 | +13.63% since 08/20/19 | -9.77% since 01/19/24 |
Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
High | 1.3100 on 10/04/22 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
6-Month | |||||
%Chg | -93.12% since 06/17/22 | -4.68% since 10/19/23 | -15.21% since 10/19/23 | +14.14% since 05/20/19 | +7.59% since 10/19/23 |
Low | 0.0760 on 12/16/22 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
High | 3.2500 on 07/08/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
Key Statistics | |||||
Market Capitalization, $K | 11,770 | 140,812,720 | 82,374,304 | 77,035,920 | 101,698,464 |
Shares Outstanding, K | 144,955 | 535,919 | 1,245,077 | 711,714 | 258,459 |
Annual Sales | 148,760,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
Annual Net Income | -264,520,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
Last Quarter Sales | 30,660,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
Last Quarter Net Income | -56,010,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
60-Month Beta | 0.24 | 0.58 | 0.19 | 1.41 | 0.35 |
Per-Share Information | |||||
Most Recent Earnings | -0.39 on 11/09/22 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
Latest Earnings Date | 11/09/22 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 29.25 |